AXSM
NASDAQ · Pharmaceuticals
Axsome Therapeutics Inc
$207.78
-6.50 (-3.03%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+76.85%
YTD
+16.28%
Open$212.05
Previous Close$214.28
Day High$213.27
Day Low$206.92
52W High$260.19
52W Low$113.85
Volume—
Avg Volume620.3K
Market Cap11.22B
P/E Ratio—
EPS$-3.76
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$171.07
Above
SMA 200
$131.37
Above
RSI (14)
51.8
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
28 analysts
Price Target
-68.2% upside
Current
$207.78
$207.78
Target
$66.03
$66.03
$47.60
$66.03 avg
$88.20
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 693.33M | 1.74B | 1.62B |
| Net Income | -198,905,011 | 523.27M | 458.37M |
| Profit Margin | -28.7% | 30.1% | 28.3% |
| EBITDA | -185,437,962 | 948.73M | 868.54M |
| Free Cash Flow | — | 423.20M | 592.85M |
| Rev Growth | +133.7% | -6.3% | -6.3% |
| Debt/Equity | 3.25 | 0.60 | 0.65 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,152.93 | +0.04% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.99 | -0.09% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $146.87 | -0.19% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.66 | +0.07% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $63.06 | +0.35% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.40 | -2.22% | 11.5 | 30.15B |